Sector revisions Exelixis, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-09-04 EDT			5-day change	1st Jan Change
59.01 ^USD	-0.20%		+8.37%	+34.63%

08-31	Exelixis Wins Appeal in Patent Case Against MSN Laboratories	MT
08-05	Exelixis, Inc., Q2 2026 Earnings Call, Aug 05, 2026

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Visibility	Nbr of analysts
EXELIXIS, INC.		16
WUXI APPTEC CO., LTD.		18
ARGENX SE		15
INSMED INCORPORATED		22
WUXI BIOLOGICS (CAYMAN) INC.		24
BIONTECH SE		20
GENMAB A/S		15
PHARMAESSENTIA CORPORATION		8
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.		18
SUMMIT THERAPEUTICS INC.		13
MADRIGAL PHARMACEUTICALS, INC.		16
ARROWHEAD PHARMACEUTICALS, INC.		11
AKESO, INC.		21
CYTOKINETICS, INCORPORATED		20
VAXCYTE, INC.		9
REMEGEN CO., LTD.		16
IMMUNITYBIO, INC.		4
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.	-	-
BELITE BIO, INC		9
Average		15
Weighted average by Cap.		17